Department of Pediatric Gastroenterology, Hepatology and Nutrition, Mersin University Faculty of Medicine, Mersin, Turkey.
Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.
Eur J Endocrinol. 2021 Nov 10;185(6):841-854. doi: 10.1530/EJE-21-0915.
CAV1 encodes caveolin-1, a major protein of plasma membrane microdomains called caveolae, involved in several signaling pathways. Caveolin-1 is also located at the adipocyte lipid droplet. Heterozygous pathogenic variants of CAV1 induce rare heterogeneous disorders including pulmonary arterial hypertension and neonatal progeroid syndrome. Only one patient was previously reported with a CAV1 homozygous pathogenic variant, associated with congenital generalized lipodystrophy (CGL3). We aimed to further delineate genetic transmission, clinical, metabolic, and cellular characteristics of CGL3.
DESIGN/METHODS: In a large consanguineous kindred referred for CGL, we performed next-generation sequencing, as well as clinical, imagery, and metabolic investigations. We studied skin fibroblasts from the index case and the previously reported patient with CGL3.
Four patients, aged 8 months to 18 years, carried a new homozygous p.(His79Glnfs*3) CAV1 variant. They all displayed generalized lipodystrophy since infancy, insulin resistance, low HDL-cholesterol, and/or high triglycerides, but no pulmonary hypertension. Two patients also presented at the age of 15 and 18 years with dysphagia due to achalasia, and one patient had retinitis pigmentosa. Heterozygous parents and relatives (n = 9) were asymptomatic, without any metabolic abnormality. Patients' fibroblasts showed a complete loss of caveolae and no protein expression of caveolin-1 and its caveolin-2 and cavin-1 partners. Patients' fibroblasts also displayed insulin resistance, increased oxidative stress, and premature senescence.
The CAV1 null variant investigated herein leads to an autosomal recessive congenital lipodystrophy syndrome. Loss of caveolin-1 and/or caveolae induces specific manifestations including achalasia which requires specific management. Overlapping phenotypic traits between the different CAV1-related diseases require further studies.
CAV1 编码 caveolin-1,一种质膜微域(称为 caveolae)的主要蛋白,参与多种信号通路。Caveolin-1 也位于脂肪细胞的脂滴中。CAV1 的杂合致病性变体可引起罕见的异质性疾病,包括肺动脉高压和新生儿早衰综合征。之前仅报道过一例 CAV1 纯合致病性变体与先天性全身性脂肪营养不良(CGL3)相关的患者。我们旨在进一步阐明 CGL3 的遗传传递、临床、代谢和细胞特征。
在一个因 CGL 就诊的大型近亲家族中,我们进行了下一代测序以及临床、影像学和代谢研究。我们研究了来自 CGL3 指数病例和之前报道的患者的皮肤成纤维细胞。
四名年龄在 8 个月至 18 岁的患者携带新的纯合 p.(His79Glnfs*3)CAV1 变体。他们从婴儿期开始均表现出全身性脂肪营养不良、胰岛素抵抗、低高密度脂蛋白胆固醇和/或高三酰甘油,但无肺动脉高压。两名患者在 15 岁和 18 岁时还因贲门失弛缓症出现吞咽困难,一名患者出现视网膜色素变性。杂合父母和亲属(n=9)无症状,无任何代谢异常。患者的成纤维细胞完全丧失了 caveolae,并且 caveolin-1 及其 caveolin-2 和 cavin-1 伴侣的蛋白表达缺失。患者的成纤维细胞还表现出胰岛素抵抗、氧化应激增加和过早衰老。
本文研究的 CAV1 无效变体导致常染色体隐性先天性脂肪营养不良综合征。caveolin-1 和/或 caveolae 的缺失导致特定的表现,包括贲门失弛缓症,需要特定的治疗。不同 CAV1 相关疾病之间存在重叠的表型特征,需要进一步研究。